187 related articles for article (PubMed ID: 32945371)
41. Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.
Wang X; Du Z; Li L; Shi M; Yu Y
Int J Clin Exp Pathol; 2015; 8(9):10644-52. PubMed ID: 26617774
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
43. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
44. Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer.
Liang JZ; Li YH; Zhang Y; Wu QN; Wu QL
Int J Clin Exp Pathol; 2015; 8(3):2937-45. PubMed ID: 26045802
[TBL] [Abstract][Full Text] [Related]
45. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
[TBL] [Abstract][Full Text] [Related]
46. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1.
Suzuki J; Nakajima W; Suzuki H; Asano Y; Tanaka N
Biochem Biophys Res Commun; 2017 Jan; 482(4):1334-1340. PubMed ID: 27939888
[TBL] [Abstract][Full Text] [Related]
47. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
48. Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy.
Zheng H; Zhang Y; Zhan Y; Liu S; Lu J; Wen Q; Fan S
Oncol Rep; 2019 Dec; 42(6):2363-2370. PubMed ID: 31638235
[TBL] [Abstract][Full Text] [Related]
49. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
[TBL] [Abstract][Full Text] [Related]
50. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
Liu Y; Tian J; Qin D; Liu J; Xie Y
J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer.
Lafuente-Sanchis A; Zúñiga Á; Galbis JM; Cremades A; Estors M; Martínez-Hernández NJ; Carretero J
Clin Transl Oncol; 2016 Aug; 18(8):798-804. PubMed ID: 26542178
[TBL] [Abstract][Full Text] [Related]
52. miR-455-3p serves as prognostic factor and regulates the proliferation and migration of non-small cell lung cancer through targeting HOXB5.
Gao X; Zhao H; Diao C; Wang X; Xie Y; Liu Y; Han J; Zhang M
Biochem Biophys Res Commun; 2018 Jan; 495(1):1074-1080. PubMed ID: 29170127
[TBL] [Abstract][Full Text] [Related]
53. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
54. Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer.
Pøhl M; Olsen KE; Holst R; Donnem T; Busund LT; Bremnes RM; Al-Saad S; Andersen S; Richardsen E; Ditzel HJ; Hansen O
Acta Oncol; 2016; 55(2):167-77. PubMed ID: 26057535
[TBL] [Abstract][Full Text] [Related]
55. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
56. Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications.
Mohamed S; Yasufuku K; Nakajima T; Hiroshima K; Chiyo M; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Agamy G; El-Shahhat H; Fujisawa T; Yoshino I
Eur Respir J; 2009 Jan; 33(1):127-33. PubMed ID: 18715879
[TBL] [Abstract][Full Text] [Related]
57. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
58. CHAF1B promotes proliferation and reduces apoptosis in 95‑D lung cancer cells and predicts a poor prognosis in non‑small cell lung cancer.
Duan Y; Liu T; Li S; Huang M; Li X; Zhao H; Li J
Oncol Rep; 2019 Apr; 41(4):2518-2528. PubMed ID: 30720130
[TBL] [Abstract][Full Text] [Related]
59. High expression of SRY-box transcription factor 30 associates with well differentiation, absent lymph node metastasis and predicts longer survival in nonsmall-cell lung cancer patients.
Liu C; Liu Y; Tian J; Zhang S; Li X; Zhai X; Feng Q
Medicine (Baltimore); 2020 May; 99(20):e20122. PubMed ID: 32443323
[TBL] [Abstract][Full Text] [Related]
60. Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer.
Chen J; Jiang T; Yu B; Li T; Zhao P; Yuan L; Qi J
Cancer Biomark; 2020; 28(4):439-446. PubMed ID: 32508320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]